Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by BlueMetal75on Aug 28, 2018 1:06pm

74 Views

Post# 28530428

RE:RE:RE:So 230 million shares, fully diluted

enriquesuave wrote: You are correct. I was off a bit.

busterbrown27 wrote: 19,071,940 at a price of .54 until March 3, 2020 = 10 Million
10,538,599 at a price of .375 until Nov 10, 2021 = 4 Million
5,113,300 at a price of .30 until may 14 2020 = 1.5 Million
28,600,00 at a price of .50 until Sept 2020? = 14 Million

If all warrants are exercised there is about 30 million more dollars for "the coffers"

Ok, 30 million, not close to $50 million. So won't get us ALL the way through the Phase II, but at least well into it. Hopefully good interim data comes out to boost the SP.

Bullboard Posts

FE Battery Metals begins 2024 winter drill program